Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
Report: Polypharmacy climbed among older adults from 1999 to 2020
By
Kristen Fischer
Jul 08, 2024
The number of older Americans over the age of 65 not living in healthcare facilities who used prescription medications rose from 1999 through the mid-2000s and hasn’t changed much since. The percentage...